Global Varicose Vein Treatment Market

Varicose Vein Treatment Market was valued at USD 566.46 Mn in 2025, and total global Varicose Vein Treatment Market revenue is expected to grow at a CAGR of 6.8% from 2026 to 2032, reaching nearly 897.77 Mn, driven by Tech Advancements.

Varicose Vein Treatment Market Overview

Varicose Veins Treatment aims to reduce pain, prevent complications and improve appearance. Varicose Vein Treatment Market is global industry involved in the development and distribution of medical devices and procedures to treat varicose veins, including endovenous ablation, sclerotherapy and surgery. It improves vascular health, aesthetics and patient outcomes through minimally invasive solutions. Major driver is increasing demand for cost effective, minimally invasive treatments with fewer complications and faster recovery times. On supply side, innovations in laser and radiofrequency technologies, along with growing clinical research are boosting advanced product availability.

North America dominates the market due to high disease prevalence, advanced healthcare infrastructure and presence of top players like Medtronic and Boston Scientific. Asia Pacific is fastest growing region due to rising disposable income, an aging population and expanding medical tourism. Key players include Medtronic plc, Boston Scientific and Angio Dynamics, which invest significantly in R&D.

Report covers the Varicose Veins Treatment Market dynamic, structure by analysing the market segments and projecting Varicose Veins Treatment Market size. Clear representation of competitive analysis of key players by, price, financial position, product portfolio, growth strategies and regional presence in Vagus Nerve Stimulator Market.

To know about the Research Methodology :- Request Free Sample Report

Varicose Vein Treatment Market Dynamics

Cost-effective Treatment Devices to Boost the Varicose Vein Treatment Market Growth

Endovenous laser ablation devices are more frequently used to treat varicose veins and are also used in wide clinical research. However, endogenous laser operations are more expensive than other procedures like vein stripping, foam fillers, electrical blasting, and others. As a result, manufacturers are shifting their preference toward introducing cost-effective Endovenous laser ablation devices that may reduce the cost of treatment procedures and drive Varicose Vein Treatment Market growth during the forecasted period. Also, the use of endovenous laser ablation devices has applications in consequences like thrombophlebitis, nerve damage, burns, and deep vein thrombosis disorders. Market players are developing innovative devices that produce fewer complications to address this issue. These factors can generate profitable opportunities for manufacturers and help grow the varicose vein treatment market.

Factors that Restraining the Growth of the Market

Side effects of Endovenous laser therapy treatment are most are aching and bruising at the wound site, temporary numbness in the leg, or pain and inflammation in the length of the treated vein, which may stay for up to 2 weeks in some patients This causes neuropraxia, which is the sensation of pins and needles or leg erythema and reddening. Additionally, the majority of leg veins carry a potential danger of blood clot formation, deep vein thrombosis, and leg infections. Additionally, the expansion of the industry is being hindered by alternative treatments for varicose veins. Varicose veins can be treated using a variety of medical techniques in addition to laser therapy. Worldwide, varicose veins are being treated by vein stripping, high ligation, and natural therapies.

Varicose Vein Treatment Market Segment Analysis

Based on Treatment mode, the varicose vein treatment market was dominated by the Injection sclerotherapy segment. The reasons for this segment's dominance are many benefits of Injection sclerotherapy treatment, such as fewer bruises and scars, no need for anaesthesia, shorter hospital stays, easy follow-up care, and advantageous payment policies. Notably, Medicare covers patients receiving Injection sclerotherapy in the United States. Three categories are used to further classify the market into surgical ligation and stripping, sclerotherapy, and Endovenous ablation. The Endovenous ablation market is expected to develop at the fastest compound annual growth rate of all of these throughout the forecasted period. Because Endovenous ablation operations are less invasive and have a lower rate of complications, they are preferable over traditional techniques such as surgical ligation and stripping. Market players are actively focusing on the development of efficient and technologically advanced products, which is expected to drive market growth.

Based on End User, the global varicose vein treatment market can be segmented by end-use into vein clinics, hospitals, and ambulatory care units. Among these segments, hospitals have traditionally been the dominant end-user for the varicose vein treatment market. In addition to providing a wide range of medical services, hospitals are well-equipped with the knowledge and resources needed to correctly identify and treat varicose veins. They frequently have sections or centers with a specific focus on vascular conditions, such as varicose veins. For patients who need more sophisticated treatment choices or surgical treatments, hospitals are the preferable option due to their superior medical equipment and capacity to manage complicated cases. Conversely, a rapidly expanding market niche within the varicose vein treatment industry is vein clinics. The diagnosis and treatment of venous problems, such as varicose veins, are the exclusive focus of vein clinics. These clinics focus on giving patients with venous disorders specialized care, and they frequently provide a range of treatment choices, including minimally invasive procedures.

Varicose Vein Treatment Market Regional Analysis

In 2025, North America held the largest share of the global Varicose Vein Treatment Market, and this trend is expected to hold for the duration of the forecast period. The increasing prevalence of varicose veins in the area and the increased acceptance of varicose vein treatment methods and technologies in the United States and Canada are also contributing to the growth of the Varicose Vein Treatment Market in North America. Prominent manufacturers such as Angio Dynamics, Inc., Boston Scientific Corporation, DJO, LLC, Viatris, Inc., and Teleflex Incorporated are also heavily represented in the area, which helps with early market access and product availability. On the other hand, the Asia Pacific area is expected to increase at the fastest CAGR. Numerous variables, such as the region's sizable senior population, growing disposable income, and growing awareness of varicose vein treatment options, are contributing to this increase. As the population ages and disposable income levels rise, more people are looking for varicose vein treatments, which is driving the Asia Pacific market's growth.

Varicose Vein Treatment Market Competitive Landscape

Competition among the key Players in Varicose Vericose Vein Treatment Market includes Medtronic plc, Boston Scientific Corportaion and Angio Dynamics. Medtronic plc is leading global varicose vein treatment market with its minimally invasive solutions, notably VNUS ClosureFast radiofrequency ablation system. In 2025, Medtronic reported, with nearly 8% allocated to R&D, over its strong commitment to innovation. With a vast vascular solutions portfolio and a robust global distribution network, Medtronic maintains dominance across North America and Europe. Boston Scientific Corporation, is a key player recognized for its endovenous laser treatment technologies and comprehensive vascular access systems.

Company invested approximately USD 1.2 billion in R&D, advancing minimally invasive, durable therapies for chronic venous conditions. Boston Scientific continues to expand aggressively into Asia and South America, strengthening its global reach. Angio Dynamics Inc, specializes in vascular and venous therapies, including laser and thermal ablation systems. In 2025, the company channels over 9% of its earnings into R&D, prioritizing innovation in catheter-based technologies. It is widely used VenaCure EVLT system is popular in ambulatory and outpatient care settings, offering a clinically effective solution for varicose vein treatment.

Varicose Vein Treatment Market Trends

Varicose Vein Treatment Market Key Developments

• In 2025, Jeisys Medical Inc., launched a new Doppler guided intravascular laser ablation system aimed at enhancing precision in varicose vein therapy, with regulatory submissions underway in key APAC market.

• In 2024, Classys Inc., expanded its vascular laser platform into China, securing CE and CFDA (now NMPA) approvals, aiming to enter Sino Korean aesthetic and vascular treatment markets.

• 24th April, 2024, Medtronic released randomized controlled trial data from its VenaSeal Spectrum Program, comparing its tissue adhesive system against surgical stripping and endothermal ablation. Findings showed superior patient satisfaction and comparable six month closure rates, reinforcing its efficacy and safety profile in treating superficial venous disease.

• 15th February 2024, Angio dynamics Inc, sold its PICC & Midline catheter product lines to Spectrum Vascular for up to USD 45 million, enabling increased focus on high-growth vascular platforms and streamlining manufacturing footprint.

• In 2022, Biolitec AG, released its next-generation Leonardo dual-wavelength laser platform, enhancing modalities for ELVeS and broader minimally invasive treatments.

Varicose Vein Treatment Market Scope: Inquiry Before Buying

Varicose Vein Treatment Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Varicose Vein Treatment Market Key Players

North America
1. Medtronic plc (U.S)
2. Angio Dynamics Inc. (U.S)
3. Boston Scientific (U.S)
4. Teleflex Incorporated (U.S)
5. Sciton Inc. (U.S)
6. Merit Medical Systems (U.S)
7. Stellite Medical (U.S)
8. Venclose Inc. (U.S)
9. Centro for Vein Restoration (U.S)
10. Metro Vein Centers (U.S)
11. Methapharm Inc. (Canada)

Europe
12. Biolitec AG (Germany)
13. Dornier MedTech GmbH (Germany)
14. El.En Group (Italy)
15. Alma Lasers Ltd. (Israel)
16. Theraclion (France)
17. Eufoton S.r.l. (Italy)

Asia-Pacific
18. Wuhan Gigaa Optronics Technology Co., Ltd. (China)
19. Beijing ADSS Development Co., Ltd. (Beijing, China)
20. Shenzhen Beautylight Technology Co., Ltd. (China)
21. Sincoheren Scientific Group (China)
22. Eunsung Global Corp. (South Korea)
23. JEISYS Medical Inc. (South Korea)
24. Hironic Co., Ltd. (South Korea)
25. Classys Inc. (South Korea)
Middle East & Africa
26. VVT Medical Ltd.
27. MediGroup
28. Al Zahrawi Medical

South America
29. BIOLASE (Brazil)
30. Condor Medical Devices (Brazil)